HOLX Financial Facts

Cost of product sales: 195.5M
Research and development: 62.5M
See Full Income Statement

Deferred service obligations - long-term: -41.1M
Accumulated deficit: 6.79B
See Full Balance Sheet

Hologic Inc. (HOLX) Earnings

  |   Expand Research on HOLX
Next EPS Date 7/29/21 *Est. EPS Growth Rate +354.4% *Last Qtr.
Average EPS % Beat Rate +49.9% Revenue Growth Rate +103.4% *Last Qtr.
Average % Move 1-Wk after EPS +3.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/28/21 Q221 $2.59$2.57 +$0.02$1.54B$1.53B Details
1/27/21 Q121 $2.86$2.17 +$0.69$1.61B$1.4B = Details
11/4/20 Q420 $2.07$1.22 +$0.85$1.35B$1.12B Details
7/29/20 Q320 $0.75$0.38 +$0.37$822.9M$616.69M Details
4/29/20 Q220 $0.57$0.57 $0.00$756.1M$745.9M = Details
1/29/20 Q120 $0.61$0.61 $0.00$850.5M$839.82M = Details
11/6/19 Q419 $0.65$0.65 $0.00$865.8M$845.73M = Details
7/31/19 Q319 $0.63$0.61 +$0.02$852.4M$835.74M = Details